FDA warns of pet owners using animals to get opioids
The US Food and Drug Administration has raised alarm about one way people might access opioids to misuse and abuse: their pets. (Source: CNN.com - Health)
Source: CNN.com - Health - August 16, 2018 Category: Consumer Health News Source Type: news

Zakah Life Recalls Kratom Because Of Possible Health Risk
Zakah Life, LLC of Ankeny, Iowa, is recalling the following Kratom products (Super Green Maeng Da Premium Kratom powder, Powerful Red Vein Bali Premium Kratom powder, Super Green Maeng Da Premium Kratom capsules, and Powerful Red Vein Bali Premium Kratom capsules) with expiration dates prior to 01/01/2023 because they have the potential of being contaminated with Salmonella, an organism which can cause serious and sometimes fatal infections in young children, frail or elderly people, and others with weakened immune systems. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 16, 2018 Category: Food Science Source Type: news

Marsee Baking Issues Allergy Alert On Undeclared Peanuts In Cookies Sold At Caf é Yumm! Restaurants
Marsee Foods, Inc. dba Marsee Baking is voluntarily recalling chocolate chip, ginger spice, and oatmeal raisin cookies sold at Caf é Yumm! restaurants. The cookies may contain undeclared peanuts. People who have an allergy or severe sensitivity to peanuts run the risk of serious or life-threatening allergic reaction if they consume these products. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 15, 2018 Category: Food Science Source Type: news

Recall Alert: FDA Warning About Two Thyroid Medications
By Sandee LaMotte, CNN (CNN) — Certain batches of hypothyroid medications are being recalled by Westminster Pharmaceuticals after one of its Chinese suppliers failed a US Food and Drug Administration inspection. The medication in question contains a combination of levothyroxine, called LT4, and liothyronine, called LT3. Both are synthetic thyroid hormones used when a person’s thyroid gland is no longer functioning properly. “While we stand behind the quality of our product, we are taking the utmost precaution by recalling our Thyroid, USP Tablets only to the wholesale level due to a recent inspection by t...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - August 15, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News CNN Local TV Thyroid Source Type: news

Statement by FDA Commissioner Scott Gottlieb, M.D., on the FDA ’s new resource guide to support responsible opioid prescribing for pain management in animals
Statement by FDA Commissioner Scott Gottlieb, M.D., on the FDA ’s new resource guide in support of responsible opioid prescribing for safe, effective pain management in animals (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 15, 2018 Category: American Health Source Type: news

Can an App Prevent Pregnancy?
By the time Jackie Blume was in her early 20s, like many women her age, she’d been taking the Pill every day for nearly a decade. When she was 23, Blume — now 28 and living in Wilmington, North Carolina — started embracing a more “natural” lifestyle, which for her meant paying attention to what she ate, and avoiding cleaning products, cosmetics, and shampoos that contained certain ingredients. “I wanted to cut things out of my life that were putting unnecessary chemicals in my body,” says Blume. “It led me to question whether my birth control pills were harming me.” Whi...
Source: TIME: Health - August 15, 2018 Category: Consumer Health News Authors: Alexandra Sifferlin Tags: Uncategorized Reproductive Health Source Type: news

Salt & Straw Voluntarily Recalls Certain Lots of Chocolate Gooey Brownie Ice Cream Pints Due to Possible Undeclared Peanuts
Salt& Straw Ice Cream is voluntarily recalling a limited number of its Chocolate Gooey Brownie pints because it may contain undeclared peanuts. People who have an allergy or severe sensitivity to peanuts run the risk of a serious or life threatening allergic reaction if they consume this product. The product is safe to consume unless you have a peanut allergy or sensitivity. No illnesses have been reported to date in connection with this problem. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 15, 2018 Category: Food Science Source Type: news

FDA Allows Marketing of First Direct-to-Consumer App for Contraceptive Use to Prevent Pregnancy
The U.S. Food and Drug Administration permitted marketing of the first mobile medical application (app) that can be used as a method of contraception to prevent pregnancy. The app, called Natural Cycles, contains an algorithm that calculates the days of the month a woman is likely to be fertile based on daily body temperature readings and menstrual cycle information, a method of contraception called fertility awareness. (Source: eHealth News EU)
Source: eHealth News EU - August 14, 2018 Category: Information Technology Tags: Featured Industry Business and Industry Source Type: news

World Organix, LLC Issues Voluntary Nationwide Recall of Blissful Remedies Red Maeng Da 100% Mitragyna Speciosa, Blissful Remedies Red Maeng Da Liquid Kratom Mitragyna Speciosa, Blissful Remedies 4 Hour Chill Slow Motion Blend, Due to High Microbial Loads Contamination
World Organix LLC, is voluntarily recalling lot: 112710 of Blissful Remedies Red Maeng Da 100% Mitragyna Speciosa capsules, Blissful Remedies Red Maeng Da Liquid Kratom Mitragyna Speciosa, Blissful Remedies 4 Hour Chill Slow Motion Blend to the consumer level. These products have been tested by the U.S. Food and Drug Administration ( “FDA”) and found to be contaminated with High Microbial Loads. Additionally, this serves as a update to a previous press release posted on June 30th 2018, concerning Blissful Remedies Gold Series Ultra Enhanced Indo and Blissful Remedies Kratom+CBD, CBD infused Maeng Da, Red Maeng ...
Source: Food and Drug Administration - August 13, 2018 Category: Food Science Source Type: news

Why you need sodium, and how much is necessary – too much or too little causes health issues
(Natural News) It is no secret that most of us consume way more sodium than our bodies need. The latest nutritional analysis done by the Food and Drug Administration (FDA) states that, on average, we consume 50 percent more sodium than we need every day. Multiply that by the number of years we’ve gorged on... (Source: NaturalNews.com)
Source: NaturalNews.com - August 13, 2018 Category: Consumer Health News Source Type: news

FDA approves first consumer app for contraceptive use
The U.S. Food and Drug Administration for the first time has approved marketing of a mobile app as a contraception method to prevent pregnancy. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 13, 2018 Category: Consumer Health News Source Type: news

FDA Warns Against Long-Term Azithromycin Use for Some
MONDAY, Aug. 13, 2018 -- The U.S. Food and Drug Administration is warning patients with cancers of the blood or lymph nodes who undergo a donor stem cell transplant not to take azithromycin, as long-term use of the antibiotic has been associated... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 13, 2018 Category: Pharmaceuticals Source Type: news

Health Tip: Most Americans are Overweight
-- More than 70 percent of Americans are overweight or obese, the U.S. Food and Drug Administration says. About 38 percent of those people are considered obese, the agency says. Obesity raises a person's risk for health problems, such as diabetes,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 13, 2018 Category: General Medicine Source Type: news

FDA grants Breakthrough Therapy Designation for Xolair (omalizumab) for food allergies
Roche announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Xolair ® (omalizumab) for the prevention of severe allergic reactions following accidental exposure to one or more foods in people with allergies. (Source: Roche Investor Update)
Source: Roche Investor Update - August 13, 2018 Category: Pharmaceuticals Source Type: news

FDA now harvesting "fresh" aborted baby tissue to create "humanized mice"
(Natural News) Using plants like cannabis (marijuana) and mitragyna speciosa (kratom) to support your health is considered “evil” by the U.S. Food and Drug Administration (FDA). But this same federal regulatory body sees absolutely no problem with extracting “fresh” body parts from aborted human babies and injecting their tissue into “humanized mice” in order to... (Source: NaturalNews.com)
Source: NaturalNews.com - August 11, 2018 Category: Consumer Health News Source Type: news

FDA approves first birth control app
The US Food and Drug Administration has given its approval for marketing of a mobile medical app to prevent pregnancy, along with a vaginal ring that protects against pregnancy for one year. (Source: CNN.com - Health)
Source: CNN.com - Health - August 11, 2018 Category: Consumer Health News Source Type: news

FDA Approves Galafold (migalastat) for the Treatment of Fabry Disease
August 10, 2018 -- The U.S. Food and Drug Administration today approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease. The drug is indicated for adults with Fabry disease who have a genetic mutation... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 11, 2018 Category: Drugs & Pharmacology Source Type: news

FDA approves 1st birth control app, vaginal contraception ring
The US Food and Drug Administration has given its approval for marketing of a mobile medical app to prevent pregnancy, along with a vaginal ring that protects against pregnancy for one year. (Source: CNN.com - Health)
Source: CNN.com - Health - August 10, 2018 Category: Consumer Health News Source Type: news

Westminster Pharmaceuticals, LLC. Issues Voluntary Nationwide Recall of Levothyroxine and Liothyronine (Thyroid Tablets, USP) Due to Risk of Adulteration
Westminster Pharmaceuticals, LLC is voluntarily recalling all lots, within expiry, of Levothyroxine and Liothyronine (Thyroid Tablets, USP) 15 mg, 30 mg, 60 mg, 90 mg,& 120 mg to the wholesale level. These products are being recalled as a precaution because they were manufactured using active pharmaceutical ingredients that were sourced prior to the FDA ’s Import Alert of Sichuan Friendly Pharmaceutical Co., Ltd., which as a result of a 2017 inspection were found to have deficiencies with Current Good Manufacturing Practices (cGMP). Substandard cGMP practices could represent the possibility of risk being introduc...
Source: Food and Drug Administration - August 10, 2018 Category: Food Science Source Type: news

FDA approves new treatment for a rare genetic disorder, Fabry disease
FDA approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 10, 2018 Category: American Health Source Type: news

FDA Approves Annovera (segesterone acetate and ethinyl estradiol) Vaginal Contraceptive System
NEW YORK, Aug. 10, 2018 /PRNewswire/ -- The Population Council, a global nonprofit research organization, announced it has received U.S. Food and Drug Administration (FDA) approval for Annovera ™ (segesterone acetate and ethinyl estradiol vaginal... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 10, 2018 Category: Drugs & Pharmacology Source Type: news

FDA Approves Onpattro (patisiran) Targeted RNA-based Therapy for Polyneuropathy Caused by hATTR
August 10, 2018 -- The U.S. Food and Drug Administration today approved Onpattro (patisiran) infusion for the treatment of peripheral nerve disease (polyneuropathy) caused by hereditary transthyretin-mediated amyloidosis (hATTR) in adult patients.... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 10, 2018 Category: Drugs & Pharmacology Source Type: news

FDA approves new vaginal ring for one year of birth control
FDA approved Annovera (segesterone acetate and ethinyl estradiol vaginal system), a combined hormonal contraceptive for women of reproductive age used to prevent pregnancy and is the first vaginal ring contraceptive that can be used for an entire year. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 10, 2018 Category: American Health Source Type: news

FDA approves first-of-its kind targeted RNA-based therapy to treat a rare disease
FDA approves new drug for treatment of polyneuropathy caused by hereditary transthyretin-mediated amyloidosis (hATTR). This is the first FDA-approved treatment for this rare, debilitating and often fatal genetic disease and the first FDA approval of a new class of drugs called small interfering ribonucleic acid (siRNA) treatment. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 10, 2018 Category: American Health Source Type: news

FDA allows marketing of first direct-to-consumer app for contraceptive use to prevent pregnancy
The app uses basal body temperature readings to predict when a woman is most fertile to help her avoid conceiving on those days if using as a form of contraception (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 10, 2018 Category: American Health Source Type: news

FDA approves first-of-its kind targeted RNA-based therapy to treat a rare disease
The U.S. Food and Drug Administration today approved Onpattro (patisiran) infusion for the treatment of peripheral nerve disease (polyneuropathy) caused by hereditary transthyretin-mediated amyloidosis (hATTR) in adult patients. This is the first FDA-approved treatment for patients with polyneuropathy caused by hATTR, a rare, debilitating and often fatal genetic disease characterized by the buildup of abnormal amyloid protein in peripheral nerves, the heart and other organs. (Source: World Pharma News)
Source: World Pharma News - August 10, 2018 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

FDA approves focused US blood-brain barrier study
The U.S. Food and Drug Administration (FDA) has given clearance to researchers...Read more on AuntMinnie.comRelated Reading: MITA to promote focused ultrasound Astronauts use ultrasound to measure spinal health Acertara teams with John Hopkins on focused US study SonaCare HIFU prostate registry reaches milestone Focused Ultrasound Foundation lands $10M gift (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 10, 2018 Category: Radiology Source Type: news

FDA Approves Arakoda (tafenoquine) for the Prevention of Malaria
WASHINGTON, Aug. 9, 2018 /PRNewswire/ -- 60 Degrees Pharmaceuticals (60P) announced today the U.S. Food and Drug Administration (FDA) approval of Arakoda (tafenoquine) tablets for the prevention of malaria in patients aged 18 years and older. For... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 9, 2018 Category: Drugs & Pharmacology Source Type: news

Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Valsartan Tablets, USP, 40mg, 80mg, 160mg and 320mg Due to The Detection of Trace Amounts of N-Nitrosodimethylamine (NDMA) Impurity, Found in an Active Pharmaceutical Ingredient (API)
As a precautionary measure, Camber Pharmaceuticals, Inc. is voluntarily recalling all unexpired lots of Valsartan Tablets, USP, 40mg, 80mg, 160mg and 320mg to the hospital, retail and consumer level. This recall of multiple batches of Valsartan Tablets was prompted due to the detection of trace amounts of N-Nitrosodimethylamine (NDMA), a possible process impurity or contaminant in an active pharmaceutical ingredient, manufactured by Hetero Labs Limited, Unit – I (API manufacturer). (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 9, 2018 Category: Food Science Source Type: news

FDA stops Fla. center from performing mammograms
The U.S. Food and Drug Administration (FDA) has ordered a Florida radiology...Read more on AuntMinnie.comRelated Reading: FDA hits firm with thermography warning letter FDA warns Ga. mammo practice of MQSA violations FDA says film printing optional for mammography FDA issues adverse MQSA report for ND hospital FDA issues breast thermography warning (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 9, 2018 Category: Radiology Source Type: news

How low can these Colorado biotech's shares go?
Last week, shares in Ampio Pharmaceuticals Inc. were trading at more than $3. Today, they're trading around 37 cents. It hasn't been a pretty freefall for the Douglas County biotech's shares (NYSE: AMPE). The freefall started yesterday, when Ampio announced that the U.S. Food and Drug Administration wanted more testing on Ampio's knee osteoarthritis drug Ampion. A current trial that would support the safety and efficacy of Ampion "does not appear to provide sufficient evidence of effectiveness,"… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 9, 2018 Category: Biotechnology Authors: Ben Miller Source Type: news

" Country Favor Inc Issues Alert on Undeclared Sulfites in “Best Taste Brand Snack Ginger Sliced”
Country Favor Inc. of Maspeth, New York is recalling its 7 ounce packages of “Best Taste Brand Snack Ginger Sliced” food treats because they contained undeclared sulfites. Consumers who have severe sensitivity to sulfites run the risk of serious or life-threatening allergic reactions if they consume this product. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 9, 2018 Category: Food Science Source Type: news

Pharma exports up 3 pc to $17.3 billion in 2017-18
Import alerts by the US Food and Drug Administration, regulatory hurdles and currency fluctuation also contributed to slow growth in the overseas shipments, an industry expert said. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - August 9, 2018 Category: Pharmaceuticals Source Type: news

FDA Approves Poteligeo (mogamulizumab-kpkc) for Mycosis Fungoides and S ézary Syndrome
August 8, 2018 -- The U.S. Food and Drug Administration today approved Poteligeo (mogamulizumab-kpkc) injection for intravenous use for the treatment of adult patients with relapsed or refractory mycosis fungoides (MF) or S ézary syndrome (SS) after... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 8, 2018 Category: Drugs & Pharmacology Source Type: news

FDA panel recommends approval of Paratek's antibiotic
A Food and Drug Administration advisory panel has recommended approval of an experimental medicine, in both intravenous and oral forms, developed by Paratek Pharmaceuticals to treat skin infections and pneumonia. The FDA's Antimicrobials Drug Advisory Committee voted 17-to-1 to recommend approval of the new drug candidate, an antibiotic called omadacycline, for the treatment of acute bacterial skin and skin structure infections. The committee voted 14-4 to recommend approval of omadacycline for… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 8, 2018 Category: Biotechnology Authors: John George Source Type: news

FDA panel recommends approval of Paratek's antibiotic
A Food and Drug Administration advisory panel has recommended approval of an experimental medicine, in both intravenous and oral forms, developed by Paratek Pharmaceuticals to treat skin infections and pneumonia. The FDA's Antimicrobials Drug Advisory Committee voted 17-to-1 to recommend approval of the new drug candidate, an antibiotic called omadacycline, for the treatment of acute bacterial skin and skin structure infections. The committee voted 14-4 to recommend approval of omadacycline for… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 8, 2018 Category: Pharmaceuticals Authors: John George Source Type: news

FDA panel recommends approval of Paratek's antibiotic
A Food and Drug Administration advisory panel has recommended approval of an experimental medicine, in both intravenous and oral forms, developed by Paratek Pharmaceuticals to treat skin infections and pneumonia. The FDA's Antimicrobials Drug Advisory Committee voted 17-to-1 to recommend approval of the new drug candidate, an antibiotic called omadacycline, for the treatment of acute bacterial skin and skin structure infections. The committee voted 14-4 to recommend approval of omadacycline for… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 8, 2018 Category: Biotechnology Authors: John George Source Type: news

FDA panel recommends approval of Paratek's antibiotic
A Food and Drug Administration advisory panel has recommended approval of an experimental medicine, in both intravenous and oral forms, developed by Paratek Pharmaceuticals to treat skin infections and pneumonia. The FDA's Antimicrobials Drug Advisory Committee voted 17-to-1 to recommend approval of the new drug candidate, an antibiotic called omadacycline, for the treatment of acute bacterial skin and skin structure infections. The committee voted 14-4 to recommend approval of omadacycline for… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 8, 2018 Category: Pharmaceuticals Authors: John George Source Type: news

FDA Approves Poteligeo for Rare Types of Non-Hodgkin Lymphoma
WEDNESDAY, Aug. 8, 2018 -- Poteligeo (mogamulizumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with two rare types of non-Hodgkin lymphoma. The drug was approved to treat relapsed or refractory mycosis... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 8, 2018 Category: Pharmaceuticals Source Type: news

U.S. FDA panel backs approval of Paratek's antibiotic
A U.S. Food and Drug Administration expert panel on Wednesday voted in favor of approval of Paratek Pharmaceuticals Inc's antibiotic to treat bacterial pneumonia and skin infections. (Source: Reuters: Health)
Source: Reuters: Health - August 8, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

FDA alerts healthcare providers, women about risks associated with improper use of rupture of membranes tests
(Source: Food and Drug Administration)
Source: Food and Drug Administration - August 8, 2018 Category: American Health Source Type: news

Product Quest Manufacturing LLC Issues Voluntary Nationwide Recall of CVS Health 12 Hour Sinus Relief Nasal Mist Due to Microbiological Contamination
Holly Hill, FL, Product Quest Manufacturing ( “Product Quest”) is voluntarily recalling Lot# 173089J of CVS Health 12 Hour Sinus Relief Nasal Mist, a clear, colorless liquid, to the consumer level. The product was found to have had microbiological contamination identified as Pseudomonas aeruginosa. (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 8, 2018 Category: Food Science Source Type: news

FDA expands recall of blood pressure drug valsartan due to cancer concern
The US Food and Drug Administration expanded the list of drugs being recalled that contain valsartan. The drug is used as a component in a set of drugs used to treat heart failure and blood pressure. (Source: CNN.com - Health)
Source: CNN.com - Health - August 8, 2018 Category: Consumer Health News Source Type: news

New Treatment for Non-Hodgkin Lymphoma Approved
WEDNESDAY, Aug. 8, 2018 -- Poteligeo (mogamulizumab) injection has been approved by the U.S. Food and Drug Administration to treat adults with two types of non-Hodgkin lymphoma. The drug was approved to treat relapsed or refractory mycosis... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 8, 2018 Category: General Medicine Source Type: news

FDA approves treatment for two rare types of non-Hodgkin lymphoma
FDA approves new drug for the treatment of adults with relapsed or refractory mycosis fungoides or S ézary syndrome after at least one prior systemic therapy (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 8, 2018 Category: American Health Source Type: news

FDA approves first generic drug under new pathway aimed at enhancing market competition for sole source drugs
FDA approves first generic drug under Competitive Generic Therapy (CGT) designation for products with inadequate generic competition (Source: Food and Drug Administration)
Source: Food and Drug Administration - August 8, 2018 Category: American Health Source Type: news

FDA approves treatment for two rare types of non-Hodgkin lymphoma
The U.S. Food and Drug Administration today approved Poteligeo (mogamulizumab-kpkc) injection for intravenous use for the treatment of adult patients with relapsed or refractory mycosis fungoides (MF) or Sézary syndrome (SS) after at least one prior systemic therapy. This approval provides a new treatment option for patients with MF and is the first FDA approval of a drug specifically for SS. (Source: World Pharma News)
Source: World Pharma News - August 8, 2018 Category: Pharmaceuticals Tags: Featured FDA Regulatory Affairs Source Type: news

Envoy wins FDA nod for MRI-conditional ear implant
Hearing device developer Envoy Medical has received U.S. Food and Drug Administration...Read more on AuntMinnie.com (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - August 8, 2018 Category: Radiology Source Type: news

Paratek Antibiotic Noninferior to Current Treatments-FDA Staff Paratek Antibiotic Noninferior to Current Treatments-FDA Staff
Paratek Pharmaceuticals Inc's new antibiotic for bacterial pneumonia and skin infections is not inferior to current treatments, U.S. Food and Drug Administration staff reviewers said on Monday.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 8, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

UCLA Health joins nationwide clinical trial for acute myeloid leukemia
UCLA Health has joined an important national clinical trial that uses genetic testing to match people who have acute myeloid leukemia, or AML, with new therapies. UCLA ’s hospital system is the first in California to offer people the opportunity to participate.The Beat AML Master Trial will evaluate a precision-based medicine approach to treating the disease; it will allow people with the disease to have immediate access to new treatments that are currently in development without having to try more traditional approaches first. The approach could streamline a patient ’s course of treatment and, ultimately, save...
Source: UCLA Newsroom: Health Sciences - August 8, 2018 Category: Universities & Medical Training Source Type: news